Journal article
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer
Abstract
Importance: The 21-gene assay recurrence score is increasingly used to personalize treatment recommendations for systemic therapy in postmenopausal women with estrogen receptor (ER)- or progesterone receptor (PR)-positive, node-positive breast cancer; however, the relevance of the 21-gene assay to radiotherapy decisions remains uncertain.
Objective: To examine the association between recurrence score and locoregional recurrence (LRR) in a …
Authors
Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA
Journal
JAMA Oncology, Vol. 6, No. 4, pp. 505–511
Publisher
American Medical Association (AMA)
Publication Date
April 1, 2020
DOI
10.1001/jamaoncol.2019.5559
ISSN
2374-2437